Journal article
The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review
Abstract
BackgroundSub optimal levels of compliance and persistence with bisphosphonates are potentially compromising the reduction of post menopausal osteoporotic (PMO) fracture risk.MethodsA structured literature search (1990–2006) was performed to identify primary research studies evaluating the relationship between compliance and persistence with bisphosphonates and post menopausal osteoporotic (PMO) fracture risk in clinical practice. Search …
Authors
Adachi J; Lynch N; Middelhoven H; Hunjan M; Cowell W
Journal
BMC Musculoskeletal Disorders, Vol. 8, No. 1,
Publisher
Springer Nature
Publication Date
December 2007
DOI
10.1186/1471-2474-8-97
ISSN
1471-2474